176 related articles for article (PubMed ID: 15012907)
1. Isolation and characterization of raw heparin from dromedary intestine: evaluation of a new source of pharmaceutical heparin.
Warda M; Gouda EM; Toida T; Chi L; Linhardt RJ
Comp Biochem Physiol C Toxicol Pharmacol; 2003 Dec; 136(4):357-65. PubMed ID: 15012907
[TBL] [Abstract][Full Text] [Related]
2. Dromedary glycosaminoglycans: molecular characterization of camel lung and liver heparan sulfate.
Warda M; Linhardt RJ
Comp Biochem Physiol B Biochem Mol Biol; 2006 Jan; 143(1):37-43. PubMed ID: 16298150
[TBL] [Abstract][Full Text] [Related]
3. Turkey intestine as a commercial source of heparin? Comparative structural studies of intestinal avian and mammalian glycosaminoglycans.
Warda M; Mao W; Toida T; Linhardt RJ
Comp Biochem Physiol B Biochem Mol Biol; 2003 Jan; 134(1):189-97. PubMed ID: 12524047
[TBL] [Abstract][Full Text] [Related]
4. Structural characterization of human liver heparan sulfate.
Vongchan P; Warda M; Toyoda H; Toida T; Marks RM; Linhardt RJ
Biochim Biophys Acta; 2005 Jan; 1721(1-3):1-8. PubMed ID: 15652173
[TBL] [Abstract][Full Text] [Related]
5. Structural analysis and biological activity of a highly regular glycosaminoglycan from Achatina fulica.
Liu J; Zhou L; He Z; Gao N; Shang F; Xu J; Li Z; Yang Z; Wu M; Zhao J
Carbohydr Polym; 2018 Feb; 181():433-441. PubMed ID: 29253994
[TBL] [Abstract][Full Text] [Related]
6. A non-hemorrhagic hybrid heparin/heparan sulfate with anticoagulant potential.
Brito AS; Cavalcante RS; Palhares LC; Hughes AJ; Andrade GP; Yates EA; Nader HB; Lima MA; Chavante SF
Carbohydr Polym; 2014 Jan; 99():372-8. PubMed ID: 24274520
[TBL] [Abstract][Full Text] [Related]
7. Isolation and characterization of low molecular weight glycosaminoglycans from marine mollusc Amussium pleuronectus (linne) using chromatography.
Saravanan R; Shanmugam A
Appl Biochem Biotechnol; 2010 Mar; 160(3):791-9. PubMed ID: 19184547
[TBL] [Abstract][Full Text] [Related]
8. Heparin from bovine intestinal mucosa: glycans with multiple sulfation patterns and anticoagulant effects.
Tovar AM; Capillé NV; Santos GR; Vairo BC; Oliveira SN; Fonseca RJ; Mourão PA
Thromb Haemost; 2012 May; 107(5):903-15. PubMed ID: 22437650
[TBL] [Abstract][Full Text] [Related]
9. Analysis of Heparins Derived From Bovine Tissues and Comparison to Porcine Intestinal Heparins.
St Ange K; Onishi A; Fu L; Sun X; Lin L; Mori D; Zhang F; Dordick JS; Fareed J; Hoppensteadt D; Jeske W; Linhardt RJ
Clin Appl Thromb Hemost; 2016 Sep; 22(6):520-7. PubMed ID: 27084870
[TBL] [Abstract][Full Text] [Related]
10. Disaccharide analysis and molecular mass determination to microgram level of single sulfated glycosaminoglycan species in mixtures following agarose-gel electrophoresis.
Volpi N
Anal Biochem; 1999 Sep; 273(2):229-39. PubMed ID: 10469494
[TBL] [Abstract][Full Text] [Related]
11. Isolation and characterization of heparin from tuna skins.
Jeske WP; McDonald MK; Hoppensteadt DA; Bau EC; Mendes A; Dietrich CP; Walenga JM; Coyne E
Clin Appl Thromb Hemost; 2007 Apr; 13(2):137-45. PubMed ID: 17456622
[TBL] [Abstract][Full Text] [Related]
12. Isolation and characterization of a heparin with high anticoagulant activity from the clam Tapes phylippinarum: evidence for the presence of a high content of antithrombin III binding site.
Cesaretti M; Luppi E; Maccari F; Volpi N
Glycobiology; 2004 Dec; 14(12):1275-84. PubMed ID: 15253929
[TBL] [Abstract][Full Text] [Related]
13. Platelet factor 4 neutralizes heparan sulfate-enhanced antithrombin inactivation of factor Xa by preventing interaction(s) of enzyme with polysaccharide.
Fiore MM; Kakkar VV
Biochem Biophys Res Commun; 2003 Nov; 311(1):71-6. PubMed ID: 14575696
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms for the anticoagulant effect of heparin and related polysaccharides.
Ofosu FA
Nouv Rev Fr Hematol (1978); 1988; 30(3):155-60. PubMed ID: 2971155
[TBL] [Abstract][Full Text] [Related]
15. Enzymatic preparation of heparin disaccharides as building blocks in glycosaminoglycan synthesis.
Kim YS; Thanawiroon C; Bazin HG; Kerns RJ; Linhard RJ
Prep Biochem Biotechnol; 2001 May; 31(2):113-24. PubMed ID: 11426699
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Low-Molecular-Weight Heparins Prepared From Bovine Lung Heparin and Porcine Intestine Heparin.
Guan Y; Xu X; Liu X; Sheng A; Jin L; Linhardt RJ; Chi L
J Pharm Sci; 2016 Jun; 105(6):1843-1850. PubMed ID: 27238483
[TBL] [Abstract][Full Text] [Related]
17. Structural characterization and functional effects of a circulating heparan sulfate in a patient with hepatocellular carcinoma.
Wages DS; Staprans I; Hambleton J; Bass NM; Corash L
Am J Hematol; 1998 Aug; 58(4):285-92. PubMed ID: 9692391
[TBL] [Abstract][Full Text] [Related]
18. Biospecific extraction and neutralization of anticoagulant heparin with fibroblast growth factors (FGF).
Luo Y; Cho HH; McKeehan WL
J Pharm Sci; 2003 Oct; 92(10):2117-27. PubMed ID: 14502551
[TBL] [Abstract][Full Text] [Related]
19. Structure and anticoagulant activity of fucosylated glycosaminoglycan degraded by deaminative cleavage.
Zhao L; Lai S; Huang R; Wu M; Gao N; Xu L; Qin H; Peng W; Zhao J
Carbohydr Polym; 2013 Nov; 98(2):1514-23. PubMed ID: 24053834
[TBL] [Abstract][Full Text] [Related]
20. Rat heparan sulphates. A study of the antithrombin-binding properties of heparan sulphate chains from rat adipose tissue, brain, carcase, heart, intestine, kidneys, liver, lungs, skin and spleen.
Horner AA
Biochem J; 1990 Mar; 266(2):553-9. PubMed ID: 2138457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
